Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

Inclusion Criteria: * 18 years of age or older * English Speaking * SARS CoV-2 infection as documented by laboratory nucleic acid amplification test or antibody test ≥ 6 months from screening or signed attestation of positive test result * Experiencing PASC symptoms ≥ 6 months * Objective cognitive impairment on neuropsychological measures (as defined by a z-score ≥1 standard deviation below the normative mean) in executive functioning * Individuals of childbearing age agreeing to use a highly effective form of birth control Exclusion Criteria: * History of cognitive dysfunction present prior to SARS CoV-2 infection * Febrile (\> 99 F) at the time of the enrollment visit * Enrollment in another interventional clinical trial in the last 90 days or during the study period * Recent SARS CoV-2 reinfection in the last 30 days or during the study period * Recent SARS CoV-2 vaccination in the last 30 days or plans to be vaccinated during the 8 week study period * Currently taking immunomodulatory medication on an ongoing basis (NSAIDs, corticosteroids, cytokine antagonists, IVIG) * History of bipolar disorder, psychotic disorder, substance use disorder * Change in anti-depressant or other psychoactive medication or dose in the last 90 days * Cranially implanted devices or metal * Any serious unstable medical or neurologic condition * History of severe head injury (as defined by loss of consciousness for ≥30 minutes) or stroke in the past 12 months * Pregnant or plan to become pregnant during the study as indicated by positive pregnancy test * Serious immune/autoimmune diagnoses prior to SARS-CoV-2 infection * ME/CFS diagnosis prior to first SARS-CoV-2 infection * Existing diagnosis of Post-treatment Lyme Disease Syndrome * Inability to achieve appropriate positioning of the study device on the head